FDA Inspection 1111335 — American Red Cross Blood Services (The)

American Red Cross Blood Services (The) — FEI 1000123713

The FDA completed an inspection of American Red Cross Blood Services (The) on November 1, 2019 in Newark, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 1, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, CA (United States)